| Literature DB >> 32587488 |
Sara Mahmoud Zayed1, Ahmed Adel Abdel Hakim1.
Abstract
BACKGROUND: Photobiomodulation (PBM) has been shown to have a positive effect on dental implant osseointegration and stability in in vitro and animal studies; however, its usefulness in dental implant clinical practice is yet unclear.Entities:
Keywords: Dental implants; implant stability; low-level laser/light therapy; osseointegration; photobiomodulation
Year: 2020 PMID: 32587488 PMCID: PMC7305678 DOI: 10.4103/sjmms.sjmms_410_19
Source DB: PubMed Journal: Saudi J Med Med Sci ISSN: 2321-4856
List of articles excluded after full-text assessment and reason for exclusion
| Study | Reason for exclusion |
|---|---|
| Sleem | PBM combined with platelet-rich fibrin - which may influence PBM effect |
| Flieger | Orthodontic mini-implants |
| Marañón-Vásquez | Orthodontic mini-implants |
| Arakeeb | PBM combined with growth factors |
| Abohabib | Orthodontic mini-implants |
| Mikhail | PBM combined with Vitamin C, omega-3 and calcium therapy |
| Awad | Diabetic patients included in the study |
| Yanaguizawa | Orthodontic mini-implants |
PBM – Photobiomodulation
Figure 1Flow diagram showing the screening and selection of articles
Description of the included studies
| Point of comparison | Author | ||||||
|---|---|---|---|---|---|---|---|
| García-Morales | Mandić | Memarian | Torkzaban | Matys | Gokmenoglu | Karaca | |
| Country | Brazil | Serbia | Iran | Iran | Poland | Turkey | Turkey |
| Study design | Split mouth (RCT) | Split mouth (RCT) | Split mouth (RCT) | Different individuals (RCT) | Different individuals (RCT) | Different individuals (non-RCT) | Different individuals (non-RCT) |
| Control | Placebo | Placebo | Placebo | Placebo | Placebo | Placebo | Placebo |
| Sample size | 8 | 12 | 12 | 19 | 24 | 15 | 25 |
| Gender | 2 males 6 females | 6 males 6 females | Not reported | 9 males 10 females | 16 males 8 females | 9 males 6 females | 11 males 14 females |
| Mean age (years), range | 36, 20-55 | 61.28, 55-75 | Not reported | Male: 40.8 Female: 43 | 46.7±8.7 | Control: 45.87+13.46 LED: 50.43+9.25 | 51.2±2.3, 36-64 |
| Ethical approval | Yes | Yes | Not reported | Yes | Yes | Yes | Yes |
| Implant type and dimensions | XiVE-S implants (Dentsply, Germany) Diameter: 3.8 mm Length: 11 mm | Self-tapping implants BlueSky® (Bredent, Germany) Diameter: 4 mm Length: 10 mm | DIO implants (invasive fungal infectionstissue level) with resorbable blast media surface (Korea) Dimensions not reported | DIO UF implants (Korea) Diameter: 4-4.5 mm Length: 10-11.5 mm | Superline (Dentium, Korea) Diameter: 4.5 mm Length: 10-12 mm | XiVE-S implants (Dentsply, Germany) Control diameter: 3.8 (3.5-4.5) mm Length: 11 mm LED: Diameter: 4.5 (3.8-4.5) mm Length: 11.0 (10.6-11.0) | DTI Implant Systems (Turkey) Diameter: 4-4.5 mm Length: 10 mm |
| Implant position | Posterior mandible | Posterior maxilla | Anterior mandible | Posterior maxilla | Posterior mandible | Not reported | Posterior mandible |
| Laser type and wavelength | GaAlAs 830 nm | GaAlAs 637 nm | Diode 810 nm, LED 626 nm | Diode 940 nm | Diode 635 nm | LED 626 nm | GaAlAs 830 nm |
| PBM parameters | 86mW, CW 0.25 J, 3s/point, 20 points 0.0028 cm2, 3.71 W/cm2 92.1 J/cm2, in contact | 40mW, CW, 6.26 J/cm2 per implant Noncontact (1 cm) | 50mw, CW 50 mw/cm2 20 J/cm2 In contact 185 mW, 38.5 mW/cm2, 46.2 J/cm2 Transcutaneous | 100 mw, CW 354.6 mw/cm2, 14.18 J/cm2 In contact | 100 mw, CW 0.5 cm2 199.04 mW/cm2 8 J/cm2 In contact | 185 mW; 222 J; 20 min 38.5 mW/cm2; 46.2 J/cm2 Transcutaneous | 86 mW, CW 0.0028 cm2, 0.25J per point, 3.71 W/cm2 92.1 J/cm2, in contact |
| Number of applications | 7 | 7 | 5 | 6 | 6 | 9 | 7 |
| Analysis conducted | ISQ assessed by RFA | ISQ by RFA+ALP activity and early implant success rate | Implant stability By periotest + IL1β, PGE2 | ISQ assessed by RFA | Implant stability By periotest & Bone Density by CBCT | ISQ by RFA and IL-1β, TGF-b, PGE2, NO levels in peri-implant crevicular fluid | ISQ assessed by RFA |
| Follow up | 12 weeks | 6 weeks | 8 weeks | 12 weeks | 12 weeks | 12 weeks | 6 months |
| Results | No effect on implant stability | No significant influence on osseointegration of self-tapping Implants placed into low-density bone | Positive effect on the stability of the implants 3 weeks and no effect on the level of IL1β and PGE2 in 4 and 8 weeks | No significant effect on dental implant stability | PBM enhanced secondary implant stability and bone density | Positive effect on osseointegration and implant stability In LED group, a negative correlation found between PGE2 and ISQ values | Positive effect on dental implant stability |
RCT – Randomized clinical trial; LED – Light-emitting diodes; ISQ – Implant stability quotient; RFA – Resonance frequency analysis; IL-1β – Interleukin-1β; TGF-β – Transforming growth factor-β; PGE2 – Prostaglandin-E2; NO – Nitric oxide; ALP – Alkaline-phosphatase; CBCT – Cone-beam computed tomography
Risk-of-bias assessment of the included randomized clinical trials according to Cochrane Risk of Bias Assessment Tool
| Domain | Authors | ||||
|---|---|---|---|---|---|
| García-Morales | Mandić | Memarian | Torkzaban | Matys | |
| Random sequence generation (selection bias) | + | + | + | + | + |
| Allocation concealment (selection bias) | + | + | ? | ? | ? |
| Blinding of participants and personnel (performance bias) | + | + | ? | ? | ? |
| Blinding of outcome assessment (detection bias) | + | + | ? | ? | ? |
| Incomplete outcome data (attrition bias) | + | + | + | + | + |
| Selective outcome reporting (reporting bias) | + | + | + | + | + |
| Other potential threats to validity | + | + | ? | + | + |
| Risk of bias | Low | Low | Unclear | Unclear | Unclear |
+ – Low risk of bias; ? – Unclear risk of bias
Risk-of-bias assessment of the included nonrandomized clinical trials with the ROBINS-I tool
| ROBIN-I item | Study | |
|---|---|---|
| Gokmenoglu | Karaca | |
| Bias due to confounding | Moderate | Moderate |
| Bias in the selection of participants | Moderate | Low |
| Bias in the classification of interventions | Low | Low |
| Bias due to deviations from intended interventions | Low | Low |
| Bias due to missing data | Moderate | Low |
| Bias in the measurement of outcomes | Moderate | Moderate |
| Bias in selection of the reported result | Low | Low |
| Overall bias | Moderate | Moderate |